| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: present invention concerns area of medical products, in particular to structure for oral tablets with the modified release, containing fine gliclazide for depression of level of a glucose in blood with defined granulat metric structure, and also the agent modifying liberation, for gliclazide release control; and fine gliclazide for depression of level of a glucose in blood has certain profiles of dissolution in the cleared water. Besides the invention concerns the way of reception of the specified structure. ^ EFFECT: decrease of level of glucose in the blood during long period of time. ^ 8 cl, 3 dwg, 9 tbl, 8 ex |
